| 0 (0%) | 10-15 12:10 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7 |
1-year : | 8.31 |
| Resists | First : | 5.99 |
Second : | 7.11 |
| Pivot price | 5.34 |
|||
| Supports | First : | 4.17 |
Second : | 3.47 |
| MAs | MA(5) : | 5.28  |
MA(20) : | 5.39 |
| MA(100) : | 5.34 |
MA(250) : | 8.17 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 32.4 |
D(3) : | 28.4 |
| RSI | RSI(14): 49.6 | |||
| 52-week | High : | 14.15 | Low : | 3.59 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ RCEL ] has closed above bottom band by 36.6%. Bollinger Bands are 65.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.32 - 5.34 | 5.34 - 5.35 |
| Low: | 5.09 - 5.11 | 5.11 - 5.13 |
| Close: | 5.23 - 5.27 | 5.27 - 5.3 |
Wed, 15 Oct 2025
How RCEL stock valuations compare to rivals - 2025 Year in Review & Real-Time Stock Entry Alerts - newser.com
Thu, 09 Oct 2025
Weiss Ratings Reaffirms Sell (D-) Rating for Avita Medical (NASDAQ:RCEL) - MarketBeat
Fri, 03 Oct 2025
AVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, - GlobeNewswire
Fri, 03 Oct 2025
AVITA Medical, Inc. (NASDAQ:RCEL) Surges 28% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Fri, 03 Oct 2025
AVITA Medical, Inc. (NASDAQ:RCEL) Surges 28% Yet Its Low P/S Is No Reason For Excitement - Sahm
Thu, 18 Sep 2025
AVITA Medical: Reimbursement Reset And Breakeven Path By 2026 (NASDAQ:RCEL) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 27 (M) |
| Shares Float | 26 (M) |
| Held by Insiders | 0.9 (%) |
| Held by Institutions | 29.2 (%) |
| Shares Short | 3,310 (K) |
| Shares Short P.Month | 4,600 (K) |
| EPS | -1.98 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.48 |
| Profit Margin | -68.9 % |
| Operating Margin | -60.6 % |
| Return on Assets (ttm) | -40.1 % |
| Return on Equity (ttm) | -935.8 % |
| Qtrly Rev. Growth | 21.2 % |
| Gross Profit (p.s.) | 2.33 |
| Sales Per Share | 2.77 |
| EBITDA (p.s.) | -1.67 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -36 (M) |
| Levered Free Cash Flow | -148 (M) |
| PE Ratio | -2.68 |
| PEG Ratio | 0 |
| Price to Book value | -10.98 |
| Price to Sales | 1.9 |
| Price to Cash Flow | -3.98 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|